Location History:
- Shizuoka-ken, JP (2002)
- Shizuoka, JP (2007 - 2016)
Company Filing History:
Years Active: 2002-2016
Title: Iwao Ohizumi: Innovator in Cancer Diagnosis and Treatment
Introduction
Iwao Ohizumi is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of cancer research through his innovative patents. With a total of 4 patents, Ohizumi's work focuses on methods for diagnosing and treating cancer.
Latest Patents
One of his latest patents is a method for diagnosing cancer by detecting GPC3. This method provides a novel approach to cancer diagnosis by identifying soluble glypican 3 in test samples. Another important patent is for a cell growth inhibitor containing an anti-PepT antibody. This invention demonstrates that an antibody binding to PepT exhibits cytotoxic activity and can inhibit cell growth, suggesting its potential use in cancer treatment and prevention.
Career Highlights
Throughout his career, Iwao Ohizumi has worked with prominent companies such as Chugai Seiyaku Kabushiki Kaisha and Perseus Proteomics Inc. His work in these organizations has contributed to advancements in cancer research and therapeutic development.
Collaborations
Ohizumi has collaborated with esteemed colleagues, including Tadanori Mayumi and Shinsaku Nakagawa. These partnerships have further enhanced his research and innovation in the field.
Conclusion
Iwao Ohizumi's contributions to cancer diagnosis and treatment through his patents highlight his role as a significant innovator in the medical field. His work continues to impact cancer research and offers hope for improved diagnostic and therapeutic strategies.